000 01327 a2200325 4500
005 20250512023645.0
264 0 _c19871116
008 198711s 0 0 eng d
022 _a0361-7742
040 _aNLM
_beng
_cNLM
100 1 _aSchally, A V
245 0 0 _aCurrent concept for improving treatment of prostate cancer based on combination of LH-RH agonists with other agents.
_h[electronic resource]
260 _bProgress in clinical and biological research
_c1987
300 _a173-97 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.; Review
650 0 4 _aAndrogen Antagonists
_xadministration & dosage
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aGonadotropin-Releasing Hormone
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aProlactin Release-Inhibiting Factors
_xadministration & dosage
650 0 4 _aProstatic Neoplasms
_xdrug therapy
650 0 4 _aSomatostatin
_xadministration & dosage
650 0 4 _aTriptorelin Pamoate
700 1 _aRedding, T W
700 1 _aPaz-Bouza, J I
700 1 _aComaru-Schally, A M
700 1 _aMathe, G
773 0 _tProgress in clinical and biological research
_gvol. 243A
_gp. 173-97
999 _c2895061
_d2895061